Adverse events (timing not specified) · exacerbations of COPD
Antibiotics showed no clear difference in adverse events ‐ overall (any adverse events not specified) compared with placebo overall (moderate certainty).
1 finding from 1 review
All‐cause mortality · exacerbations of COPD
Antibiotics showed no clear difference in all‐cause mortality compared with placebo (low certainty).
1 finding from 1 review
Treatment failure within 4 weeks ‐ current drugs only ‐ inpatient · exacerbations of COPD
Antibiotics showed no clear difference in treatment failure within 4 weeks ‐ current drugs only ‐ inpatient compared with placebo (moderate certainty).
1 finding from 1 review
Treatment failure within 4 weeks ‐ drugs not currently used ‐ ICU · exacerbations of COPD
Antibiotics probably leads to lower treatment failure within 4 weeks ‐ drugs not currently used ‐ ICU compared with placebo (moderate certainty).
1 finding from 1 review
Length of stay (inpatients only) · exacerbations of COPD
1 finding from 1 review
Duration of hospital stay (days) ‐ ICU patients · exacerbations of COPD
1 finding from 1 review
Inpatient mortality · exacerbations of COPD
Antibiotics showed no clear difference in all‐cause mortality ‐ inpatients compared with placebo (moderate certainty).
1 finding from 1 review
ICU mortality · exacerbations of COPD
Antibiotics probably leads to lower all‐cause mortality ‐ ICU patients compared with placebo (moderate certainty).
1 finding from 1 review
Diarrhoea · exacerbations of COPD
Antibiotics showed no clear difference in adverse events ‐ diarrhoea compared with placebo overall (moderate certainty).
1 finding from 1 review
Outcomes ( · adult kidney transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants with symptomatic UTI · adult kidney transplant recipients
Antibiotics showed no clear difference in symptomatic UTI compared with no treatment (low certainty).
1 finding from 1 review
Antimicrobial resistance · adult kidney transplant recipients
Antibiotics showed no clear difference in antimicrobial resistance compared with no treatment (low certainty).
1 finding from 1 review
All‐cause mortality · adult kidney transplant recipients
Antibiotics showed no clear difference in all‐cause mortality compared with no treatment (low certainty).
1 finding from 1 review
Graft loss · adult kidney transplant recipients
Antibiotics showed no clear difference in graft loss compared with no treatment (low certainty).
1 finding from 1 review
Acute rejection · adult kidney transplant recipients
Antibiotics showed no clear difference in acute graft rejection compared with no treatment (low certainty).
1 finding from 1 review
Hospitalisation for UTI · adult kidney transplant recipients
Antibiotics showed no clear difference in hospitalisation for UTI compared with no treatment (low certainty).
1 finding from 1 review
Graft function · adult kidney transplant recipients
1 finding from 1 review
Total postoperative infections ‐ early and late · women having elective vaginal hysterectomy
Antibiotics may leads to lower total postoperative infections ‐ early and late compared with placebo (low certainty).
1 finding from 1 review
Pelvic infection · women having elective abdominal hysterectomy
Antibiotics probably leads to lower pelvic infection compared with placebo (moderate certainty).
1 finding from 1 review
Other serious infections · women having elective abdominal hysterectomy
It is very uncertain whether antibiotics changes other serious infections compared with placebo (very low certainty).
1 finding from 1 review